Search

Inflammation and retinal degeneration in retinitis pigmentosa: Can lessons learned in the lab help us identify treatments in the clinic?

• Webinar
• Video

Funding from Retina UK has allowed to team to explore the viability of gene therapy as a treatment for RP and related conditions, and build a pipeline of clinical trials.

Our Keynote speaker will be Mr Kanmin Xue. Mr Xue is a Consultant Vitreo-retinal Surgeon at the John Radcliffe Hospital and Wellcome Trust clinician scientist fellow at the University of Oxford where he leads the Retinal Disease and Repair Group.

• Information event
• Audio
• Written

We’re all still buzzing from our recent conferences. We do hope you enjoyed them as much as we did. If you weren’t able to join us, then you can watch or listen to the recordings on our website.

• Look Forward
• Audio
• Written

Saturday 15 November 2025, 1.00pm - 4.00pm - In-person - Come and join Colin and the group at the Tyneside Irish Centre for a Christmas get together with a raffle and festive buffet lunch courtesy of the Blind Baker.

• Local Peer Support Group

This edition marks the start of the charity's 50th anniversary year. It includes lots of ways to get involved over the next 12 months along with details of our Annual and Professionals' Conferences in September.

• Look Forward
• Audio
• Written

Join the Retina UK Lottery for a weekly dose of good fortune and good deeds!

• News

Chris McCausland is heading to Blackpool for week 10 of Strictly Come Dancing.

• Story
• Retinitis pigmentosa

The development of a new treatment is a lengthy process, from early investigation of ideas and principles in the lab, through testing in cell and animal models to the final stages of clinical trials in human patients. The good news is that progress is increasingly rapid.

Growth factors are substances that promote the health and function of cells and tissues in the body.